Back to News
Market Impact: 0.25

Ex-Dividend Reminder: Elevance Health, Pathward Financial and UMB Financial

Capital Returns (Dividends / Buybacks)Company FundamentalsCorporate Earnings
Ex-Dividend Reminder: Elevance Health, Pathward Financial and UMB Financial

Elevance Health Inc (ELV), Pathward Financial Inc (CASH), and UMB Financial Corp (UMBF) are scheduled to trade ex-dividend on September 10, 2025, with their respective quarterly payouts expected to result in corresponding share price adjustments. ELV's $1.71 dividend implies a 0.55% price reduction, CASH's $0.05 a 0.07% reduction, and UMBF's $0.40 a 0.32% reduction, all else being equal. Notably, Elevance Health is identified as a 'future dividend aristocrats contender' due to its consistent dividend growth spanning over 14 years, signaling potential long-term income stability for investors.

Analysis

Elevance Health (ELV), Pathward Financial (CASH), and UMB Financial (UMBF) are set to trade ex-dividend on September 10, 2025, triggering predictable, minor adjustments in their share prices. Elevance Health's quarterly dividend of $1.71 translates to a 2.18% annualized yield, the highest of the trio, and is accompanied by a strong performance signal, with shares recently trading up 1.8%. Critically, ELV is highlighted as a 'future dividend aristocrats contender' due to its consistent dividend growth for over 14 years, signaling a robust and reliable capital return policy. In contrast, Pathward Financial offers a minimal 0.26% annualized yield, and its shares were recently down 2.5%, reflected in its negative per-ticker sentiment. UMB Financial offers a moderate 1.29% annualized yield with a slight 0.7% share price increase. The key takeaway is the differentiation in dividend profiles: ELV presents a compelling dividend growth story, whereas CASH's dividend appears nominal, and UMBF's is moderate, underscoring the importance of examining historical consistency and yield as part of due diligence.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

More News